Navigation Links
The Leukemia & Lymphoma Society: Impacting Blood Cancers and Beyond
Date:2/19/2013

PSAs and print advertising. According to Lisa Stockmon , senior vice president, marketing at LLS, "Our objective is to build brand awareness so people have more knowledge of what we do and the impact of what we do. We're telling our story in a humanistic and modern way that engages our 62 chapters and also provides a marketing umbrella for The Leukemia & Lymphoma Society, because we want to make sure people have an emotional connection and are aware of our role in the battle against blood cancers."

For more information on "Someday is Today" visit http://www.lls.org/somedayistoday/. LLS is also on Facebook and Twitter

LLS Fundraising Campaigns:  Something for Everyone

LLS fundraising campaigns reflect its broad approach to attracting individual and corporate donors, with a range of entry points and opportunities for participation. From the inception in 1988 of Team In Training®, the world's first and largest endurance training program, to the inspirational, community-oriented Light The Night® Walk events, to the family-friendly Pineapple Classic obstacle course, LLS has an extraordinary range of programs dedicated to raise awareness, participation and, most important, funds to develop and provide access to blood cancer treatments. All 62 LLS chapters in the United States and Canada are dedicated to this mission.

Innovating with Venture Philanthropy: Therapy Acceleration Program™ (TAP)

LLS launched the Therapy Acceleration Program (TAP) in 2007, to advance development of new therapies and diagnostics by bridging the gap between discovery and human applications, and to increase the likelihood that novel, even breakthrough treatments will be available to patient
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Data Presented at American Society of Hematology from Ibrutinib Phase 1b/2 and Phase 2 Trials Suggest High and Durable Response in Chronic Lymphocytic Leukemia
2. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
3. Inovio Pharmaceuticals Announces Positive Interim Results in Phase II Leukemia Trial
4. Global Acute Myeloid Leukemia (AML) Therapeutics Industry
5. The Leukemia & Lymphoma Society Awards $12 Million in Research Grants in Four Critical Areas of Unmet Medical Need
6. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
7. Study of Cell Therapeutics Tosedostat for Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Now Enrolling
8. Acute Lymphocytic Leukemia: Impressive Results With the Monoclonal Antibody Blinatumomab in Patients With Refractory Disease
9. How Malignant Cells in Patients With Chronic Lymphocytic Leukemia Escape T Cell Recognition and Attack
10. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
11. Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2015)... ... July 23, 2015 , ... July ... by providing more targeted treatment options with fewer side effects, according to Erik ... Anderson Cancer Center. , At the American Brain Tumor Association (ABTA) National Patient ...
(Date:7/23/2015)... , July 23, 2015 /PRNewswire/ - Portage Biotech Inc. ... and Biohaven Pharmaceutical Holding Company Limited (Biohaven), are ... Investigational New Drug (IND) Application with the U.S. ... testing of BHV-0223. Portage holds 54% equity interest ... is a glutamate modulating agent and Biohaven has ...
(Date:7/23/2015)... 2015 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... invites investors and the general public to its Annual ... Friday, July 31, 2015. The meeting will be held ... San Diego, California 92121.   ... also be available. Please use the following link to ...
(Date:7/23/2015)... , ... July 23, 2015 , ... Global Stem ... research in Santiago, Chile. The symposium will feature some of the world’s most ... day of high-level scientific discussion for medical professionals in general practice. , The ...
Breaking Biology Technology:Radiation Oncology Advances Improve Safety and Efficacy of Treatment for Brain Tumors 2Radiation Oncology Advances Improve Safety and Efficacy of Treatment for Brain Tumors 3Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 2Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 3Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 4OncoSec to Webcast Annual Meeting of Stockholders 2Global Stem Cells Group Announces Plans to Hold International Symposium on Stem Cells and Regenerative Medicine in Santiago, Chile Sept. 3-4, 2015 2Global Stem Cells Group Announces Plans to Hold International Symposium on Stem Cells and Regenerative Medicine in Santiago, Chile Sept. 3-4, 2015 3
... Although the <A , href="http://www.ambion.com/catalog/CatNum.php?1632"> Silencer ... for labeling siRNA, they can , be ... can be used for this application. See "<A , ... Introduced dsRNA in Cells " for experimintal data using dsRNA , ...
... , RNA later is a tissue storage , ... fresh , tissues. (Ambion's ... specifically for use with frozen tissues - see "<A , ... Grinding Frozen Tissue " for more information.) Tissue , ...
... NAVIGATE THIS ARTICLE: <A , href="#1">What , ... href="#2">Advantages , > <A , ... , href="#4">Steps , , ... a Nuclease Protection , Assay? , ...
Cached Biology Technology:Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit 2Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit 3Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit 4RNArticles: Keeping RNA Intact Prior to RNA Isolation - RNAlater 2RNArticles: Keeping RNA Intact Prior to RNA Isolation - RNAlater 3RNArticles: Keeping RNA Intact Prior to RNA Isolation - RNAlater 4RNArticles: Keeping RNA Intact Prior to RNA Isolation - RNAlater 5RNArticles: Keeping RNA Intact Prior to RNA Isolation - RNAlater 6RNArticles: Keeping RNA Intact Prior to RNA Isolation - RNAlater 7Nuclease Protection Assays: The Basics 2Nuclease Protection Assays: The Basics 3Nuclease Protection Assays: The Basics 4Nuclease Protection Assays: The Basics 5Nuclease Protection Assays: The Basics 6Nuclease Protection Assays: The Basics 7Nuclease Protection Assays: The Basics 8Nuclease Protection Assays: The Basics 9Nuclease Protection Assays: The Basics 10
(Date:7/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), a leading developer ... report financial results for the fourth quarter and fiscal ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-455-2260 (conference ...
(Date:7/8/2015)... NEW YORK , July 8, 2015  BD ... announced BD & Guidepoint Mentor, a new ... to Guidepoint,s expert network services. BD ... technologies to improve healthcare delivery and outcomes and, with ... start-up entrepreneur will be able to directly engage with ...
(Date:7/7/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... announces a revised version of one of its first 30 second ... CNBC in New York , Chicago ... San Francisco metro areas.    , , ... replace all the cards in your wallet and keep your identity ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... Soil Use and Management attempts for the first time ... globe and concludes that 24% of the land area is degrading ... decline in the quality of soil, water and vegetation is ... global data by which to assess its extent and severity. For ...
... 20, 2009 Ecopsychologyan emerging field that explores the ... in which ecology and psychology interact on individual, societal, ... peer-reviewed journal, Ecopsychology to be launched by ... ). Ecopsychology will explore the relationship ...
... good gumshoe. The University of Alberta medical geneticist has cracked ... Glaucoma is a leading cause of blindness in which cells ... what patients see. Scientists have long suspected a link between ... what the gene does and why some people with variations ...
Cached Biology News:A quarter of the world's population depends on degrading land 2New ecopsychology journal will premiere in spring 2009 2Genetic sleuth solves glaucoma mystery 2
... Loading Buffer contains a precipitant to ensure that ... tracking dye to allow the user to follow ... ReddyRun™: ABgene ® s proprietary mixture ... same buffer composition used in ReddyRun™ molecular weight ...
... number is a new ... easily match Cornings product ... availability yet, please order ... number (Z71,381-3) or contact ...
Excellent safety and durability., Remote control can be easily operated in your hand., Constant voltage control with 2 sets of terminals., Precise and durable circuit design. ...
Gel Loading Buffer contains a precipitant to ensure that the samples sink into the wells and a tracking dye to allow the user to follow the progress of electrophoresis....
Biology Products: